Novartis CEO Vas Narasimhan (L) and Pfizer CEO Albert Bourla (Akio Kon/Bloomberg via Getty Images; Hannes P Albert/picture-alliance/dpa/AP Images)
February 23, 2024 02:24 PM ESTUpdated 02:40 PM
Pharma
Marketing

Pfiz­er and No­var­tis chiefs lead phar­ma's CEO in­flu­encers on so­cial me­dia, analy­sis finds

Beth Snyder Bulik

Senior Editor

When it comes to phar­ma CEOs as so­cial in­flu­encers, Pfiz­er’s Al­bert Bourla is a per­fect 10 com­pared to his peers.

No­var­tis CEO Vas Narasimhan is …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Among phar­ma CEOs, the IRA now and the IRA lat­er get very dif­fer­ent re­ac­tions

Up­dat­ed: With cost-cut­ting un­der­way, Bris­tol My­ers rais­es guid­ance, touts Phase 3 win and scraps an­oth­er

Bris­tol My­ers restarts ra­dio­phar­ma­ceu­ti­cal Phase 3 tri­al, but de­lays read­out by one year

An­drew Left, short sell­er who cam­paigned against Valeant, is ac­cused of fraud by SEC

Eu­ro­pean drug reg­u­la­tor re­jects Alzheimer's drug Leqem­bi, cit­ing safe­ty con­cerns

sponsored

Crit­i­cal Junc­tures in Gene Ther­a­py Clin­i­cal Ma­te­r­i­al Man­u­fac­tur­ing: Where Do I Start? And Will It Work?

A service from the Financial Times